Objective: The use of computed tomography (CT) and ultrasound (US) in patients with acute abdominal pain has substantial variation across pediatric emergency departments (EDs). This study compares the cost of diagnosing and treating suspected appendicitis across a multicenter network of children's hospitals.
A bdominal pain is one the most common chief complaints for pediatric patients who present to the emergency department (ED). 1, 2 Acute appendicitis is diagnosed in 1% to 8% of these patients 3 and it is the most common surgical emergency in children. [3] [4] [5] [6] Accurate diagnosis of appendicitis reduces unnecessary surgery, while timely diagnosis minimizes the risk of appendiceal perforation. 6, 7 Over the past 20 years, computed tomography (CT) scans have facilitated improvements in our diagnostic ability due to CT's high sensitivity and specificity. 8 However, the use of CT exposes patients to ionizing radiation, which increases the risk of cancer, especially in pediatric populations. [9] [10] [11] [12] [13] [14] [15] [16] Furthermore, in one study the cost of an abdominal CT scan has been reported to be almost three times higher than the cost of an abdominal ultrasound (US). 17 Ultrasound has gained acceptance as an alternative to CT for the diagnosis of appendicitis in patients with acute abdominal pain. 18 Although US has excellent test characteristics, US performance is known to be operator dependent. [19] [20] [21] Recent publications have described the utility of incorporating US into clinical practice guidelines for children with acute abdominal pain. 20, [22] [23] [24] [25] These studies have demonstrated that US in conjunction with patient history, physical examination and basic laboratory testing, achieves test performance comparable to CT. Furthermore, US has gained rapid acceptance among children's hospitals, with one study reporting a 46% increase in use of US with a corresponding drop in CT utilization. 26 In another study, the drop in CT use was responsible for an estimated 39.4% reduction in annual imaging costs. 17 Regardless, CT use remains widespread across the United States, especially in nonpediatric centers. 27 The variation in US utilization in the United States is multifactorial. It may stem from provider and patient/parent preferences, protocol differences, differences in the availability of US, and/or differential availability of experienced pediatric US technicians. Moreover, there are little data comparing the total cost of care using different strategies to evaluate children with acute abdominal pain. Therefore, the purpose of this study was to complete an economic analysis of the cost of diagnosing and treating suspected appendicitis cases principally from the payer perspective across a multicenter network of children's hospitals that had differing diagnostic imaging practice patterns. Specifically, we hypothesized that the cost of diagnosing and treating suspected appendicitis would be less at sites that primarily used US compared to sites that primarily used CT for diagnosing appendicitis.
METHODS

Study Design and Setting
This was a secondary analysis of a prospective, observational study of patients with suspected appendicitis conducted at nine pediatric EDs. All EDs were located in children's hospitals that were members of the Pediatric Emergency Medicine Collaborative Research Committee (PEMCRC) of the American Academy of Pediatrics. Study subjects were enrolled from March 2009 through April 2010. The PEMCRC reviewed and approved the final study protocol. Each participating site's institutional review board also approved the study.
Study Patients
The study included patients aged 3 to 18 years of age who presented to the ED with acute abdominal pain of <96 hours' duration and evaluated for suspected appendicitis. "Suspected appendicitis" was defined as those patients evaluated by blood tests, radiologic studies (CT and/or US) and/or a surgical consultation for the purpose of diagnosing appendicitis. We excluded patients with any of the following conditions: prior abdominal surgery, chronic gastrointestinal illness or abdominal pain, sickle cell anemia, cystic fibrosis, a medical condition affecting the provider's ability to obtain an accurate history (e.g., language or developmental delay), or history of abdominal trauma within 7 days of evaluation. We also excluded patients who had radiologic studies (CT or US) of the abdomen performed prior to ED arrival. Study procedures related to training of site staff, patient enrollment, standardized data collection, and transmission to the central data management warehouse have been described previously. 22 
Outcome Measure
For the present analysis, the primary outcome was the total cost of care for treating suspected appendicitis cases across sites. The total cost of care included ED visit cost, CT cost, US cost, inpatient and surgery cost, cancer risk cost associated with CT imaging, and revisit cost (ED, imaging, inpatient and surgery, and higher morbidity or perforation rate) for missed appendicitis cases. All cost elements were computed from the payer perspective with the exception of CT cancer risk cost, which included the value of disabilityadjusted life-years (DALYs) lost per cancer patient. Cost for missed appendicitis captures patients who were sent home, but later had a diagnosis of appendicitis. All cost estimates are presented in 2016 dollars.
As the parent study 22 did not contain site-specific cost data, we used national data sources, namely, the Medical Expenditure Panel Survey (MEPS) and Kid's Inpatient Database (KID), to estimate the total cost of care. For each site, we applied standardized costs for each service such as a CT or US. With this standardization, the differences in costs across regions were removed. Therefore, a benefit of this approach is that costs across sites only varied due to differences in practice patterns and not charge, billing, or reimbursement differences.
Emergency department, CT, and US costs were derived based on the 2012 to 2014 MEPS. In other words, differences in cost do not reflect facility-specific or regional differences in reimbursement rates, but only differences in clinical approach. ED cost includes all facility and professional costs associated with an ED visit excluding CT and US costs (Table 1) as we separately accounted for those costs. As MEPS does not disaggregate costs for the various services received during an ED visit, we used regression analysis to estimate the cost of ED visits with and without CT and/ or US. From this analysis we estimated the average cost of an ED visit without imaging and the incremental costs associated with CT or US. Inpatient and surgery cost was based on data from the 2012 KID, which is a national, all-payer sample of pediatric inpatient stays. KID observations with an appendectomy (47.0, 47.01, or 47.09 International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM] procedure codes) and a diagnosis for nonperforated (540.9, 541, or 542 [ICD-9-CM] diagnosis codes) or perforated (540.0 or 540.1) appendicitis cases were used to estimate charges. As the KID does not include professional fees, we used a professional fee ratio of 1.242 based on a study that estimated all costs relative to facility costs to account for these costs. 28 From these charges, we estimated inpatient and surgery cost using paid-to-charge ratios for appendicitis cases from the 2012 to 2014 MEPS ( Table 1) .
The average lifetime cancer cost associated with the radiation exposure of CT imaging included the lifetime health care costs associated with cancer and the value of DALYs lost per cancer patient. Lost DALYs account for indirect costs such as early mortality and lost productivity. We estimated lifetime health care cost per cancer patient at $140,889. 29 We used lost DALYs associated with cancer 30 and the number of cancer patients from MEPS to estimate lost DALYs per cancer patient. We valued lost DALYs (0.96 per cancer patient) at $57,456 using the per capita Gross Domestic Product for 2016. Using the lifetime attributable risk of cancer associated with CT exposure, 10 which we have scaled to a typical radiation dose of 8 millisieverts for abdominal CTs, 31, 32 we estimated the average lifetime cancer cost associated per CT at $306 (Table 1 ). This level of radiation exposure was based on prior data and accounted for the median age of patients in our study (10 years) . 31 Note that due to the inclusion of DALYs in the CT cancer risk cost, this cost is the only cost element that this not strictly representative of the payer perspective. Therefore, as a CT cancer risk $317
The cost of increased cancer associated with a CT scan includes lifetime health care costs associated with cancer 31 and the value of lost DALYs. 32 The lifetime-attributable risk of cancer for a CT scan varies by age and sex. 10 Typical radiation exposure for an abdominal CT is 8 millisieverts. 31, 32 Lost DALYs were valued at per capita GDP.
All values were inflated to 2016 dollars using the Consumer Price Index. DALY = disability-adjusted life-year; GDP = Gross Domestic Product; KID = Kids' Inpatient Database; MEPS = Medical Expenditure Panel Survey; US = ultrasound;
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Creation of a Normalized Sample
The parent study included 2,625 suspected appendicitis cases across nine sites and our underlying assumption was that the baseline rate of appendicitis was similar across sites and that site-specific care patterns would not alter this rate. Although enrollment in the parent study varied by site (48% to 96%) as did the rate of appendicitis (27% to 46%), these differences were likely due to differences in study enrollment practices across sites rather than the underlying appendicitis rate as site practice patterns do not influence the underlying appendicitis rate. Thus, we normalized the sample so that the mean appendicitis rate was equal across sites. Specifically, we normalized the sample to the mean appendicitis rate of the site with the highest enrollment rate (96%), as we assumed this site would represent essentially complete data capture. To achieve this aim, we randomly removed appendicitis cases from seven sites and randomly removed nonappendicitis cases from one site. The resulting analytic data set contained 2,300 cases that had an appendicitis rate of 31.8% and perforation rate of 25.7%.
Data Analysis
Although we normalized the data to equalize the appendicitis rate across sites, the rates for negative appendectomy (patient had surgery but evidence for appendicitis was not seen on pathology) and missed appendicitis could still vary across sites due to differences in site-level imaging practice patterns and clinical characteristics. Accordingly, our methodology simultaneously controlled for differences in these rates due to demographic and clinical characteristics as well as sitelevel imaging patterns as imaging choice in each case depends on both case-specific factors and site-level practice patterns. To accomplish this, we separately predicted whether CT and US were used in each case given the demographic and clinical characteristics of the case and the average imaging patterns at the site. Specifically, we controlled for sex; age; race and ethnicity; hours of abdominal pain (<48, 48-95); focal pain in the right lower quadrant (RLQ); migration of pain to the RLQ; history of anorexia; history of nausea, vomiting, tenderness (none/mild/unknown, moderate, severe), or maximum tenderness in the RLQ; presence of rebound tenderness; guarding; pain with walking, coughing, or hopping; and absolute neutrophil count (<6 9 10 9 /L or unknown, 6 9 10 9 -12 9 10 9 /L, >12 9 10 9 /L). We then used these case-specific predicted CT and predicted US rates along with case-specific demographic and clinical characteristics to predict the impact of site-level imaging patterns on missed cases and negative appendicitis cases. A series of studies has demonstrated that imaging practices are unlikely to affect the underlying rate of appendicitis or perforation on the initial encounter; [33] [34] [35] consequently, we made the decision to apply the population appendicitis and perforation rates to each site.
We computed for each site the average total cost of care per suspected appendicitis case in the following categories: ED and imaging, surgery and inpatient, cancer risk, and revisits for missed appendicitis cases. We computed cost and outcomes, negative appendectomy and missed appendicitis, for low-risk cases (based on risk algorithms 22 ) as a theoretical assessment of cost and outcomes had these patients been sent home without advanced imaging. We compared these values with the cost and outcomes of the imaging and treatment they actually received. Standard errors for cost were bootstrapped using 500 replicates. Because we applied a standardized cost to each case based on the services received, the standard errors of our results are relatively small as this approach eliminates cost variance that is driven by differences in cost structure or reimbursement rates among sites. We also computed the correlation between both site-level CT and US rates and cost as high-level measures of the relationship between imaging practices and cost. We also compared cost differences across sites using t-tests for difference of means. All analyses were conducted with STATA version 14.0.
RESULTS
Study Population and Site Type
Of the 2,300 subjects who comprised our analytic data set, 49.0% were male and 53.6% were non-Hispanic white. The CT/US imaging practices varied substantially by site (Table 2) . Four sites used CT in over 80% of cases while using US in under 10% of cases. Conversely, three sites used US in over 90% of cases while using CT in at least 10% of cases and the remaining two sites did not predominantly use CT or US. There were significant differences in patient demographics by site, but not significant differences in the negative appendectomy rate, perforation rate, or missed appendicitis rate (Table 2) .
Differences Across Sites
After adjusting for demographic and clinical characteristics, we examined differences between sites for negative appendectomy and missed appendicitis. All sites correctly diagnosed appendicitis in over 95% of cases. The negative appendectomy rate ranged from 2.5% to 4.7% while the missed appendicitis rate ranged from 0.3% to 1.1% (Table 3 ) with no significant differences in these rates across site (Table 2) .
We found a strong positive correlation (0.95) between the site CT rate and total cost per case and a strong negative correlation (-0.71) between the site US rate and cost (Figure 1 ). Comparing cost among site type, we found significant cost differences across sites that varied 9.3% between the lowest and highest costs site. The cost per case at US sites was 5.2% or $367 less than at CT sites (p < 0.001; Table 3 ). Similarly, costs per case at mixed sites were 3.4% or $244 less than at CT sites (p < 0.001).
Beyond the primary imaging type used at a site (CT, US, or mixed), we examined the average number of CT and US images performed per patient. At sites that predominately used CT, the average CT rate was 83.7% and a minority of patients, 6.7%, underwent imaging with US (Table 3 ). Conversely at sites that used predominately US, the average US utilization was 93.0%; however, 28.2% also received a CT, a finding that is consistent with CT being utilized for cases in which the US interpretation is equivocal. This resulted in the average number of CT or US images per case of 0.9 at CT sites and 1.2 at US sites. However, despite this higher imaging utilization, the average cost per case at US sites was $6,753, 5.2% less costly than the average cost per case at CT sites, $7,120 (p < 0.001). Comparing costs among CT sites or among US sites, the cost per case generally increased as the images per case increased among both CT sites and US sites, but the costs were universally higher at CT sites ( Figure 1C ).
To further demonstrate the cost differences between CT and US, we examined cost, as a sensitivity analysis, if there was no presumed CT cancer risk (and thus no associated cost) with CT. In other words, excluding the CT cancer risk cost is equivalent to only considering the current episode cost from the payer perspective. Doing this, US sites would still have 2.8% lower cost than CT sites (p < 0.001) due to differences in the cost of CT and US imaging.
Theoretical Assessment
We examined how costs would have varied if a patient may have been managed through an appendicitis risk algorithm. We identified low-risk patients based on a a Negative appendectomy case, patient had surgery but appendicitis was negative per pathology. b Missed appendicitis case, patient sent home, but later had appendicitis. c Revisit cost for missed appendicitis cases includes ED revisit, additional imaging, inpatient and surgery cost, and additional CT cancer risk cost. Data were adjusted to control for demographic and clinical differences across sites. Adjusted data represent rates and cost that differ based on site-specific imaging patterns. The appendicitis rate is the same across all site types given the normalization of the sample. n=2300. CT, computed tomography; US, ultrasound; ED, emergency department; IP, inpatient; CI, confidence interval. previously validated decision rule for identifying lowrisk patients. 22 In our sample, 386 patients were classified as low risk following this rule and 3.4% of them had appendicitis. Of these, 76.4% received advanced imaging (46.9% CT and 40.7% US). If these patients had been discharged from the ED without imaging or surgery, the negative appendectomy rate would have been 0% and missed appendicitis rate 3.4%. The elimination of diagnostic imaging would have reduced cost per case by $791 or 32.8% (Table 4) , even after accounting for the cost of missed appendicitis cases.
DISCUSSION
In this large multicenter study of pediatric patients with suspected appendicitis our results provide support for US as the primary imaging modality as a cost-effective strategy for suspected appendicitis at pediatric institutions. Sites that preferentially utilized US had 5.2% lower costs per case for payers than sites that primarily used CT. We postulate that imaging rates across sites varied due to a combination of differences, including use of clinical practice guidelines, provider preferences, and imaging availability. Regardless of the reason, differences in practice patterns across sites resulted in a significant cost consequence without impact on the care delivered.
The results from our study are consistent with other research conducted on the cost-effectiveness of US and CT use for suspected appendicitis. Sites that predominantly use US are moderately less costly than sites that predominantly use CT. 18, 24, 36, 37 One study found that using US rather than CT in all suspected appendicitis cases reduced the cost of diagnosis and treatment by 20% with maintaining test performance. 24 Other studies have examined the cost of care with a staged imaging protocol which uses US followed by CT in negative or equivocal cases. In a study by Wan et al., 36 a staged protocol for diagnosing appendicitis had improved sensitivity (97% vs. 94%) over CT alone as well as incremental cost savings. Finally, the integration of strategies that utilize risk stratification in conjunction with a staged protocol have also demonstrated cost savings. In one recent analysis, a scheme that stratified patients into low, medium, or high risk for appendicitis and then the staged utilization of US/ CT found a further 16% reduction with negligible changes in outcomes. 18 This study lends further support on the role of US as the primary imaging modality for acute abdominal pain by demonstrating reduced costs within a geographically diverse cohort of hospitals.
Despite the lower cost for US compared to CT, the main driver of utilization should be the performance of an imaging modality. For example, the inability to hire and train US technicians may limit an ED from utilizing US out of the concern that US performance may be diminished. However, such a constraint does not prevent sites from reducing imaging through best practice pathways or risk algorithms to guide care based on risk for appendicitis. To explore this question, we examined 16.8% of our study population who were identified as low risk for appendicitis by a previously validated scoring system. 22, 23, 25, 38, 39 Among this population, the risk of appendicitis was 3.4%. However, 76.4% of these low-risk patients underwent imaging with CT or an US, with 11.2% receiving both. Forgoing CT and/ or US imaging in these cases would have theoretically reduced the cost of diagnoses and treatment by 32.8%, even after accounting for the costs of missing 3.4% of appendicitis cases.
Our study is subject to some limitations. First, actual cost data were not collected for the patients in this study, so we applied standardized cost estimates for all clinical care services each patient received. We applied the same standardized cost across all sites for each service. An advantage of this approach is that any difference in cost between sites was only associated with differences in site-specific practice patterns rather than differences in cost structure or reimbursement across sites. We used national data sources, MEPS and KID, to estimate costs rather than applying national cost estimates or costs from one or a few sites.
A further limitation is that the various sites in our study had differential enrollment processes, thus resulting in large differences in enrollment rates. To address this issue, we normalized the rate of appendicitis across the data set by randomly dropping patients from the sample so that all sites had the same appendicitis rate. Although we attempted to conduct followup on all patients discharged from the hospital to identify missed appendicitis cases, we cannot exclude the possibility that some patients may have received appendectomies at other facilities. Given that the enrolling sites were major pediatric delivery points in their respective community, we believe that this would minimally impact our data. 22 While the assumptions behind our normalization process were logical, we cannot know for certain what the appendicitis rate would have been at each site had the enrollment rate been the same across all sites. To estimate the cost of cancer risk associated with CT, [9] [10] [11] [12] [13] [14] [15] [16] we used theoretical values for the radiation dose, lifetime cancer risk for that dose, direct health care cost, indirect cost or lost DALYs, and the value of a DALY. While our estimates are based on the existing literature, we acknowledge that these are assumptions. However, as stated in our results, if our CT cancer risk estimates are low, the estimated difference in cost per case between CT and US sites would be even larger. Conversely, if there was no CT cancer risk (and no associated cost), US sites would still have a significantly lower cost than CT sites (p < 0.001) due to differences in the cost of CT and US imaging. Therefore, the inferences we have drawn from our results are not driven by the cost estimate for CT cancer risk.
A final limitation is that our study sample consists solely of pediatric institutions and all of the EDs included in the study were located in children's hospitals that were members of the PEMCRC of the American Academy of Pediatrics. Due to the high variability in performance based on sonographer experience, these findings may not be applicable to nonpediatric institutions where sonographers have less experience and/or lower performance with a pediatric population.
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CONCLUSIONS
We present the standardized cost of diagnosing appendicitis in a multicenter cohort of pediatric hospitals for patients with suspected appendicitis. The costs associated with care varied by 9.3% between the site with the lowest cost and the site with the highest cost for care. At sites where computed tomography was the preferred imaging used, costs were 5.2% higher than sites where ultrasound was the predominant imaging modality.
